(RPRX)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
Royalty Pharma plc Qo'shma Shtatlardagi biofarmatsevtika sanoatida biofarmatsevtika royalti sotib oluvchi va innovatsiyalarni moliyalashtiruvchi sifatida ishlaydi. Uning portfeli taxminan 35 ta sotuvdagi terapiya va 20 ta rivojlanish bosqichidagi mahsulot nomzodlari bo'yicha royaltilardan iborat bo'lib, ular kam uchraydigan kasalliklar, onkologiya, nevrologiya, yuqumli kasalliklar, gematologiya va diabet kabi turli terapevtik sohalarga murojaat qiladi. Kompaniya 1996 yilda tashkil etilgan va Nyu-York, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. James Folmar Reddoch Ph.D. | Executive VP of Investments & Chief Scientific Officer |
| Dr. Marshall Jonathan Urist M.D., Ph.D. | Executive Vice President of Research & Investments |
| Mr. Arthur Richard McGivern J.D. | Executive VP & Chief Legal Officer |
| Mr. Christopher Hite | Chairman of Partnering & Investments |
| Mr. Eric Cornelius Schneider | Senior VP & Chief Technology Officer |
| Mr. George Grofik C.F.A., CPA | Senior VP and Head of Investor Relations & Communications |
| Mr. Pablo Legorreta | Founder, Chairman of the Board & CEO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2025-12-22 | 8-K | d938129d8k.htm |
| 2025-11-05 | 10-Q | rprx-20250930.htm |
| 2025-09-16 | 8-K | d58607d8k.htm |
| 2025-08-13 | 8-K | d930454d8k.htm |
| 2025-08-06 | 8-K | d90343d8k.htm |
| 2025-07-17 | 8-K | d948144d8k.htm |
| 2025-05-19 | 8-K | dp228958_8k.htm |
| 2025-05-12 | 8-K | d52049d8k.htm |
| 2025-05-08 | 8-K | d938501d8k.htm |
| 2025-04-11 | DEFA14A | ef20047282_defa14a.htm |
| Mr. Sandy Balkin Ph.D. | Senior Vice President of Strategy & Analytics |
| Mr. Terrance P. Coyne | Executive VP & CFO |
| Ms. Molly Sawaya | Executive VP & Head of Human Capital |